Jobson Lopes de Oliveira

Jobson Lopes de Oliveira

Auto-generated profile, based on publicly available information

Jobson Lopes de Oliveira

Centro Universitário Christus, Brasil; Universidade Federal do Ceará, Brasil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
JOJobson Lopes de Oliveira
Jobson Lopes de Oliveira
INIgor Albuquerque Nogueira
Igor Albuquerque Nogueira
JAJose Kennedy Amaral
Jose Kennedy Amaral
LCLuciana Ribeiro Campos
Luciana Ribeiro Campos
MMMariana Macêdo Militão Mendonça
Mariana Macêdo Militão Mendonça
RSRobert Schoen
Robert Schoen
Chikungunya fever (CHIK) is a neglected tropical disease associated with chronic arthritis. CHIK is usually a self-limiting condition; however, extra-articular manifestations present as atypical illness in a minority of patients. These atypical features may mimic other conditions and potentially distract physicians from the true diagnosis. This review analyzes the evidence of many unusual extra-articular manifestations reported in cases of CHIK. Depending on the affected system, these unusual manifestations include encephalitis, myocarditis, acute interstitial nephritis, cutaneous manifestations, acute anterior uveitis, abdominal pain, and depression. In addition, coinfections and comorbidities may cause atypical illness and obscure the diagnosis. Further studies are required to clarify the pathophysiology and natural history of CHIK, as it remains a burdening condition. Exploring its atypical symptoms may be the missing scientific piece of this puzzle.

1 June 2011 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
JOJobson Lopes de Oliveira
Jobson Lopes de Oliveira
GJGeraldo Bezerra da Silva Junior
Geraldo Bezerra da Silva Junior
EDElizabeth De Francesco Daher
Elizabeth De Francesco Daher
Extrapulmonary tuberculosis (TB) account for approximately 15–20% of TB cases in immunocompetent patients. The genitourinary system is the third most commonly affected site. We report the case of a 20-year-old man admitted with fever, chills, dry cough, right flank pain, and oliguria who developed renal function loss. The pyelogram evidenced silence of the right kidney, and the abdominal and pelvic magnetic resonance showed significant dilation of the right pyelocaliceal system and proximal ureter. Biopsies of renal cortex and retroperitoneal lymph nodes showed caseous granuloma consistent with TB. Treatment was started with rifampicin, isoniazid, pyrazinamide, and ethambutol, and the patient presented a favorable outcome but with non-dialytic chronic kidney disease. This case illustrates a case of chronic kidney disease secondary to TB in a young, otherwise healthy man.

23 March 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
NMNickson Breno Maniçoba
Nickson Breno Maniçoba
INIgor Albuquerque Nogueira
Igor Albuquerque Nogueira
PCPaulo Henrique da Costa Carlos
Paulo Henrique da Costa Carlos
RRRaul Sancho de Carvalho Rocha
Raul Sancho de Carvalho Rocha
MLMicael Porto Portela Lima
Micael Porto Portela Lima
JOJobson Lopes de Oliveira
Jobson Lopes de Oliveira
Post-acute COVID-19 syndrome (also known as long COVID) refers to the persistence of COVID-19 symptoms for at least four weeks following the acute phase of the disease caused by SARS-CoV-2 infection. This study aims to provide a narrative review of the musculoskeletal manifestations of long COVID-19. While prevalence rates varied among studies, chronic fatigue, myalgia, arthralgia, and arthritis were consistently reported as the most common manifestations. Notably, a positive correlation was observed between the length of hospital stay and the likelihood of experiencing long COVID-19 symptoms. Moreover, women were found to be more susceptible to this condition than men.

1 January 2025 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
JOJobson Lopes de Oliveira
Jobson Lopes de Oliveira
INIgor Albuquerque Nogueira
Igor Albuquerque Nogueira
AEAfonso Rocha Eisele
Afonso Rocha Eisele
LFLuís Arthur B. G. Farias
Luís Arthur B. G. Farias
Methotrexate (MTX) is a cornerstone in the treatment of inflammatory arthritis owing to its immunomodulatory effects. Its use has expanded to the management of post-viral inflammatory conditions, including chronic arthritis caused by Chikungunya virus (CHIKV) infection, which may mimic rheumatoid arthritis (RA)1. Although effective, MTX poses a risk of adverse effects, including rare but potentially life-threatening complications such as pneumonitis2,3.

1 January 2023 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
INIgor Albuquerque Nogueira
Igor Albuquerque Nogueira
RCRafael Alves Cordeiro
Rafael Alves Cordeiro
GHGuilherme Alves de Lima Henn
Guilherme Alves de Lima Henn
JOJobson Lopes de Oliveira
Jobson Lopes de Oliveira

29 June 2026 in Modern Rheumatology Case Reports
Verified
Journal Article
Closed access
JOJobson Lopes de Oliveira
Jobson Lopes de Oliveira
JAJosé Kennedy Amaral
José Kennedy Amaral
INIgor Albuquerque Nogueira
Igor Albuquerque Nogueira
LFLuis Arthur Brasil Gadelha Farias
Luis Arthur Brasil Gadelha Farias
RSRobert T Schoen
Robert T Schoen
Chronic chikungunya arthritis is a debilitating post-viral inflammatory condition that clinically mimics rheumatoid arthritis and often requires long-term treatment with disease-modifying antirheumatic drugs. Treatment options are limited when conventional synthetic disease-modifying antirheumatic drugs are not tolerated or lose efficacy. We report the case of a 50-year-old Brazilian woman with serologically confirmed chikungunya virus infection who developed chronic chikungunya arthritis with a rheumatoid arthritis–like phenotype. Following an acute febrile illness accompanied by rash and negative dengue serology, she was initially managed with symptomatic analgesics, followed by prednisone and hydroxychloroquine. Despite this treatment, the disease activity score in 28 joints calculated with C-reactive protein was elevated at 6.78. Methotrexate was introduced but was discontinued after 3 weeks due to drug-induced pneumonitis. She later failed leflunomide therapy after 12 months, with a score of 4.33. Baricitinib (4 mg/day), a Janus kinase 1 and 2 inhibitor, was then initiated, resulting in marked clinical and laboratory improvement: the disease activity score decreased to 1.90 over 1 year, C-reactive protein normalised, the erythrocyte sedimentation rate declined progressively, and morning stiffness resolved, with no infectious complications. This case suggests that Janus kinase inhibition may be a therapeutic option for selected patients with chronic chikungunya arthritis refractory to conventional treatment.